Fomentariol, a <i>Fomes fomentarius</i> Compound, Exhibits Anti-Diabetic Effects in Fungal Material: An In Vitro Analysis

Abstract

The present study screened various fungal species for inhibitors of alpha-glucosidase, alpha-amylase, and DPP-4, enzymes that are crucial in carbohydrate metabolism. Ethanolic extracts exhibited superior inhibitory activity compared to water extracts, suggesting their potential as sources of anti-diabetic agents. Further fractionation revealed fomentariol from Fomes fomentarius as a potent inhibitor of alpha-glucosidase and DPP-4, with higher activity against alpha-glucosidase than acarbose. Fomentariol presents a novel avenue for diabetes management, demonstrating the simultaneous inhibition of key enzymes in glucose metabolism. However, comprehensive clinical studies are needed to evaluate its safety and efficacy in humans.

Keywords

• diabetes
• anti-diabetics
• fungi
• <i>Fomes fomentarius</i>
• fomentariol